Based on SEC filing data. A pharmaceutical corporation based in Cambridge, MA raised $7.2M in a Series B convertible note funding round. The company is in the development stage with institutional backing through this debt-to-equity conversion instrument.
Get notified the moment XRpro Sciences, Inc. files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.